ARTICLE | Clinical News
Aplidin plitidepsin regulatory update
September 26, 2016 7:00 AM UTC
PharmaMar submitted an MAA to EMA for Aplidin plitidepsin in combination with dexamethasone to treat relapsed or refractory multiple myeloma (MM). The submission is based on data from the Phase III AD...